Navian Capital is a brokerage firm that specializes in providing diverse investment solutions, including structured products and annuities, to financial professionals. They cater to banks, credit unions, broker/dealers, and Registered Investment Advisors, offering services such as custom structured product development and competitive secondary liquidations. Their investment focus includes Series B rounds, with notable investments such as Novome Biotechnologies, which has raised $43.5 million.
Navian Capital stands out with its unique capabilities, including the StARS for BDs—a five-star due diligence service for Market-Linked CDs, notes, and annuities. The firm also offers exclusive secondary offerings and robust analytics tools to help clients navigate their investments. Key partners and decision-makers at Navian Capital leverage their extensive experience to provide strategic support and tailored solutions, ensuring that financial professionals have access to high-quality, customized investment opportunities.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages

Navigate Capital Partners
navigatecap.com

Banríon Capital Management
banrioncapital.com

Brookline Capital Markets

Navy Capital
navycapital.com

Navitas Capital
navitascap.com

US Boston Capital
usboston.com

NAventures
nbc.ca

Nascent Capital

NaviMed Capital Advisors
navimed.com

Roan Capital Partners
roancp.com

Broadhaven Capital Partners
broadhaven.com

Nesvold Capital Partners
nesvold.com

Cap8
cap-8.com
Javcap Securities

Sepio Capital
sepiocap.com

Varanium Capital Advisors
varaniumgroup.com

Navis Capital Partners
naviscapital.com

Mission Capital Advisors

CapStack
capstack.com

NovaQuest Capital Management
novaquest.com